Factors associated with serum ferritin levels and iron excess: results from the EPIC-EurGast study.


Journal

European journal of nutrition
ISSN: 1436-6215
Titre abrégé: Eur J Nutr
Pays: Germany
ID NLM: 100888704

Informations de publication

Date de publication:
Feb 2022
Historique:
received: 21 12 2020
accepted: 24 06 2021
pubmed: 3 7 2021
medline: 27 1 2022
entrez: 2 7 2021
Statut: ppublish

Résumé

Excess iron is involved in the development of non-communicable diseases such as cancer, type 2 diabetes and cardiovascular conditions. We aimed to describe the prevalence of excess iron and its determinants in healthy European adults. Sociodemographic, lifestyle, iron status, dietary information, and HFE genotyping were obtained from controls from the nested case-control study EPIC-EurGast study. High sensitivity C-reactive protein (hsCRP) was measured to address possible systemic inflammation. Descriptive and multivariate analyses were used to assess iron status and its determinants. Out of the 828 participants (median age: 58.7 years), 43% were females. Median serum ferritin and prevalence of excess iron were 143.7 µg/L and 35.2% in males, respectively, and 77 µg/L and 20% in females, both increasing with latitude across Europe. Prevalence of HFE C282Y mutation was significantly higher in Northern and Central Europe (~ 11%) than in the South (5%). Overweight/obesity, age, and daily alcohol and heme iron intake were independent determinants for iron status, with sex differences even after excluding participants with hsCRP > 5 mg/L. Obese males showed a greater consumption of alcohol, total and red meat, and heme iron, compared with those normal weight. Obesity, higher alcohol and heme iron consumption were the main risk factors for excess iron in males while only age was associated with iron overload in females. Weight control and promoting healthy lifestyle may help prevent iron overload, especially in obese people. Further research is needed to clarify determinants of excess iron in the healthy adult population, helping to reduce the associated comorbidities.

Identifiants

pubmed: 34213605
doi: 10.1007/s00394-021-02625-w
pii: 10.1007/s00394-021-02625-w
doi:

Substances chimiques

Hemochromatosis Protein 0
Histocompatibility Antigens Class I 0
Ferritins 9007-73-2
Iron E1UOL152H7

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

101-114

Subventions

Organisme : Cancer Research UK
ID : 25004
Pays : United Kingdom

Informations de copyright

© 2021. Springer-Verlag GmbH Germany, part of Springer Nature.

Références

Arija V, Ribot B, Aranda N (2013) Prevalence of iron deficiency states and risk of haemoconcentration during pregnancy according to initial iron stores and iron supplementation. Public Health Nutr 16:1371–1378. https://doi.org/10.1017/S1368980013000608
doi: 10.1017/S1368980013000608 pubmed: 23472860
Peña-Rosas JP, Viteri FE (2009) Effects and safety of preventive oral iron or iron+folic acid supplementation for women during pregnancy. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD004736.pub3
doi: 10.1002/14651858.CD004736.pub3 pubmed: 19821332
Arija V, Fernández-Cao JC, Basora J et al (2014) Excess body iron and the risk of type 2 diabetes mellitus: a nested case-control in the PREDIMED (PREvention with MEDiterranean Diet) study. Br J Nutr 112:1896–1904. https://doi.org/10.1017/S0007114514002852
doi: 10.1017/S0007114514002852 pubmed: 25322842
Meidtner K, Podmore C, Kröger J et al (2018) Interaction of dietary and genetic factors influencing body iron status and risk of type 2 diabetes within the EPIC-InterAct study. Diabetes Care 41:277–285. https://doi.org/10.2337/dc17-1080
doi: 10.2337/dc17-1080 pubmed: 29167213
Podmore C, Meidtner K, Schulze MB et al (2016) Association of multiple biomarkers of iron metabolism and type 2 diabetes: The EPIC-Inter act study. Diabetes Care 39:572–581. https://doi.org/10.2337/dc15-0257
doi: 10.2337/dc15-0257 pubmed: 26861925
Jiang L, Wang K, Lo K et al (2019) Sex-specific association of circulating ferritin level and risk of type 2 diabetes: a dose-response meta-analysis of prospective studies. J Clin Endocrinol Metab 104:4539–4551. https://doi.org/10.1210/jc.2019-00495
doi: 10.1210/jc.2019-00495 pubmed: 31074789
Pourmoghaddas A, Sanei H, Garakyaraghi M et al (2014) The relation between body iron store and ferritin, and coronary artery disease. ARYA Atheroscler 10:32–36
pubmed: 24963311 pmcid: 4063519
Silvestre OM, Gonçalves A, Nadruz W et al (2017) Ferritin levels and risk of heart failure—the atherosclerosis risk in communities study. Eur J Heart Fail 19:340–347. https://doi.org/10.1002/ejhf.701
doi: 10.1002/ejhf.701 pubmed: 27976478
Chang VC, Cotterchio M, Khoo E (2019) Iron intake, body iron status, and risk of breast cancer: a systematic review and meta-analysis. BMC Cancer 19:543. https://doi.org/10.1186/s12885-019-5642-0
doi: 10.1186/s12885-019-5642-0 pubmed: 31170936 pmcid: 6555759
Toyokuni S (2009) Role of iron in carcinogenesis: cancer as a ferrotoxic disease. Cancer Sci 100:9–16. https://doi.org/10.1111/j.1349-7006.2008.01001.x
doi: 10.1111/j.1349-7006.2008.01001.x pubmed: 19018762
Cloonan SM, Mumby S, Adcock IM et al (2017) The iron-y of iron overload and iron deficiency in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 196:1103–1112. https://doi.org/10.1164/rccm.201702-0311PP
doi: 10.1164/rccm.201702-0311PP pubmed: 28410559 pmcid: 5694836
Gono T, Kawaguchi Y, Hara M et al (2010) Increased ferritin predicts development and severity of acute interstitial lung disease as a complication of dermatomyositis. Rheumatology 49:1354–1360. https://doi.org/10.1093/rheumatology/keq073
doi: 10.1093/rheumatology/keq073 pubmed: 20385617
Fonseca-Nunes A, Agudo A, Aranda N et al (2015) Body iron status and gastric cancer risk in the EURGAST study. Int J Cancer 137:2904–2914. https://doi.org/10.1002/ijc.29669
doi: 10.1002/ijc.29669 pubmed: 26135329 pmcid: 6284801
Knuiman MW, Divitini ML, Olynyk JK et al (2003) Serum ferritin and cardiovascular disease: a 17-year follow-up study in Busselton, Western Australia. Am J Epidemiol 158:144–149. https://doi.org/10.1093/aje/kwg121
doi: 10.1093/aje/kwg121 pubmed: 12851227
Barton JC, Edwards CQ, Acton RT (2015) HFE gene: structure, function, mutations, and associated iron abnormalities. Gene 574:179–192. https://doi.org/10.1016/j.gene.2015.10.009
doi: 10.1016/j.gene.2015.10.009 pubmed: 26456104 pmcid: 6660136
Katsarou MS, Papasavva M, Latsi R, Drakoulis N (2019) Hemochromatosis: hereditary hemochromatosis and HFE gene. Vitam Horm 110:201–222. https://doi.org/10.1016/bs.vh.2019.01.010
doi: 10.1016/bs.vh.2019.01.010 pubmed: 30798813
Merryweather-Clarke AT, Pointon JJ, Jouanolle AM et al (2000) Geography of HFE C282Y and H63D mutations. Genet Test 4:183–198. https://doi.org/10.1089/10906570050114902
doi: 10.1089/10906570050114902 pubmed: 10953959
Lucotte G, Dieterlen F (2003) A european allele map of the C282Y mutation of hemochromatosis: celtic versus viking origin of the mutation? Blood Cells Mol Dis 31:262–267. https://doi.org/10.1016/S1079-9796(03)00133-5
doi: 10.1016/S1079-9796(03)00133-5 pubmed: 12972035
Crownover B, Covey C (2013) Hereditary hemochromatosis. Am Fam Physician 87:183–190. https://doi.org/10.1179/1024533213Z.000000000222
doi: 10.1179/1024533213Z.000000000222 pubmed: 23418762
WHO guideline on use of ferritin concentrations to assess iron status in individuals and populations. Geneva: World Health Organization; 2020. Licence: CC BY-NC-SA 3.0 IGO.
Mura C, Le Gac G, Raguénes O et al (2000) Relation between HFE mutations and mild iron-overload expression. Mol Genet Metab 69:295–301. https://doi.org/10.1006/mgme.2000.2981
doi: 10.1006/mgme.2000.2981 pubmed: 10870847
Worwood M (2007) Indicators of the iron status of populations: ferritin. World Health Organization, Centers for Disease Control and Prevention. https://www.who.int/nutrition/publications/micronutrients/anaemia_iron_deficiency/9789241596107_annex2.pdf?ua=1
Kim H, Shin C, Baik I (2016) associations between lifestyle factors and iron overload in korean adults. Clin Nutr Res 5:270. https://doi.org/10.7762/cnr.2016.5.4.270
doi: 10.7762/cnr.2016.5.4.270 pubmed: 27812516 pmcid: 5093224
Ioannou GN, Dominitz JA, Weiss NS et al (2004) The effect of alcohol consumption on the prevalence of iron overload, iron deficiency, and iron deficiency anemia. Gastroenterology 126:1293–1301. https://doi.org/10.1053/j.gastro.2004.01.020
doi: 10.1053/j.gastro.2004.01.020 pubmed: 15131790
Shattnawi KK, Alomari M, Al-Sheyab N, Bani Salameh A (2018) The relationship between plasma ferritin levels and body mass index among adolescents. Sci Rep 8:15307. https://doi.org/10.1038/s41598-018-33534-4
doi: 10.1038/s41598-018-33534-4 pubmed: 30333502 pmcid: 6193036
Alam F, Memon AS, Fatima SS (2015) Increased body mass index may lead to hyperferritinemia irrespective of body iron stores. Pak J Med Sci 31:1521–1526. https://doi.org/10.12669/pjms.316.7724
doi: 10.12669/pjms.316.7724 pubmed: 26870128 pmcid: 4744313
Reddy KV, Shastry S, Raturi M, Baliga BP (2020) Impact of regular whole-blood donation on body iron stores. Transfus Med Hemother 47:75–79. https://doi.org/10.1159/000499768
doi: 10.1159/000499768 pubmed: 32110197
Ellulu MS, Patimah I, Khaza’ai H et al (2017) Obesity and inflammation: the linking mechanism and the complications. Arch Med Sci 13:851–863. https://doi.org/10.5114/aoms.2016.58928
doi: 10.5114/aoms.2016.58928 pubmed: 28721154 pmcid: 28721154
Elisia I, Lam V, Cho B et al (2020) The effect of smoking on chronic inflammation, immune function and blood cell composition. Sci Rep 10:1–16. https://doi.org/10.1038/s41598-020-76556-7
doi: 10.1038/s41598-020-76556-7
Burini RC, Anderson E, Durstine JL, Carson JA (2020) Inflammation, physical activity, and chronic disease: an evolutionary perspective. Sport Med Heal Sci 2:1–6. https://doi.org/10.1016/j.smhs.2020.03.004
doi: 10.1016/j.smhs.2020.03.004
Hoppe M, Brün B, Larsson MP et al (2013) Heme iron-based dietary intervention for improvement of iron status in young women. Nutrition 29:89–95. https://doi.org/10.1016/j.nut.2012.04.013
doi: 10.1016/j.nut.2012.04.013 pubmed: 22951158
Young I, Parker HM, Rangan A et al (2018) Association between haem and non-haem iron intake and serum Ferritin in healthy young women. Nutrients 10:81. https://doi.org/10.3390/nu10010081
doi: 10.3390/nu10010081 pmcid: 5793309
Jackson J, Williams R, McEvoy M et al (2016) Is higher consumption of animal flesh foods associated with better iron status among adults in developed countries? A systematic review. Nutrients 8:89. https://doi.org/10.3390/nu8020089
doi: 10.3390/nu8020089 pubmed: 26891320 pmcid: 4772052
Adams S, Sello CT, Qin GX et al (2018) Does dietary fiber affect the levels of nutritional components after feed formulation? Fibers 6:29. https://doi.org/10.3390/fib6020029
doi: 10.3390/fib6020029
Riboli E, Hunt KJ, Slimani N et al (2002) European prospective investigation into cancer and nutrition (EPIC): study populations and data collection. Public Health Nutr 5:1113–1124. https://doi.org/10.1079/PHN2002394
doi: 10.1079/PHN2002394 pubmed: 12639222
Italian Minister of Health (2005) Decree of the Italian Minister of Health. Gazz Uff della Repubb Ital 146:5–26. https://www.gazzettaufficiale.it/eli/gu/2005/04/13/85/sg/pdf
Margetts B (1997) European prospective investigation into cancer and nutrition: validity studies on dietary assessment methods. Int J Epidemiol 26(Suppl 1):S1–S5. https://doi.org/10.1093/ije/26.suppl_1.s1
doi: 10.1093/ije/26.suppl_1.s1 pubmed: 9126528
Wareham NJ, Jakes RW, Rennie KL et al (2003) Validity and repeatability of a simple index derived from the short physical activity questionnaire used in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Public Health Nutr 6:407–413. https://doi.org/10.1079/phn2002439
doi: 10.1079/phn2002439 pubmed: 12795830
Friedenreich C, Cust A, Lahmann PH et al (2007) Physical activity and risk of endometrial cancer: the European prospective investigation into cancer and nutrition. Int J Cancer 121:347–355. https://doi.org/10.1002/ijc.22676
doi: 10.1002/ijc.22676 pubmed: 17357139
Trichopoulou A, Naska A, Costacou T (2002) Disparities in food habits across Europe. Proc Nutr Soc 61:553–558. https://doi.org/10.1079/pns2002188
doi: 10.1079/pns2002188 pubmed: 12691185
Rumm-Kreuter D (2001) Comparison of the eating a nd cooking habits of northern Europe and the Mediterranean countries in the past, present and future. Int J Vitam Nutr Res 71:141–148. https://doi.org/10.1024/0300-9831.71.3.141
doi: 10.1024/0300-9831.71.3.141 pubmed: 11582834
Reyes C, Pons NA, Reñones CR et al (2020) Association between serum ferritin and acute coronary heart disease: a population-based cohort study. Atherosclerosis 293:69–74. https://doi.org/10.1016/j.atherosclerosis.2019.12.011
doi: 10.1016/j.atherosclerosis.2019.12.011 pubmed: 31865056
Díaz-López A, Iglesias Vázquez L, Pellejà-Millán M et al (2020) Association between iron status and incident type 2. Nutrients 12:3249. https://doi.org/10.3390/nu12113249
doi: 10.3390/nu12113249 pmcid: 7690731
Mckinnon EJ, Rossi E, Beilby JP et al (2014) Factors that affect serum levels of ferritin in Australian adults and implications for follow-up. Clin Gastroenterol Hepatol 12:101-108.e4. https://doi.org/10.1016/j.cgh.2013.07.019
doi: 10.1016/j.cgh.2013.07.019 pubmed: 23906872
Ueno Y, Fujita K, Takashina N et al (1991) Studies on the change in the levels of serum ferritin, serum iron and total iron binding capacity caused by aging and sex difference. Rinsho Byori 39:523–530
pubmed: 2072576
Yip R (1994) Changes in iron metabolism with age. In: Brock JH, Halliday JW, Pippard MJ, Powell LW (eds) Iron metabolism in health and disease. WB Saunders, London, pp 428–448
Picca A, Mankowski RT, Kamenov G et al (2019) Advanced age is associated with iron dyshomeostasis and mitochondrial DNA damage in human skeletal muscle. Cells 8:1525. https://doi.org/10.3390/cells8121525
doi: 10.3390/cells8121525 pmcid: 6953082
Xu J, Jia Z, Knutson MD, Leeuwenburgh C (2012) Impaired iron status in aging research. Int J Mol Sci 13(2):2368–2386. https://doi.org/10.3390/ijms13022368
doi: 10.3390/ijms13022368 pubmed: 22408459 pmcid: 3292028
Lecube A, Hernández C, Pelegrí D, Simó R (2008) Factors accounting for high ferritin levels in obesity. Int J Obes 32:1665–1669. https://doi.org/10.1038/ijo.2008.154
doi: 10.1038/ijo.2008.154
Moore Heslin A, O’Donnell A, Buffini M et al (2021) Risk of iron overload in obesity and implications in metabolic health. Nutrients 13:1539. https://doi.org/10.3390/nu13051539
doi: 10.3390/nu13051539 pubmed: 34063273 pmcid: 8147503
Traversy G, Chaput JP (2015) Alcohol consumption and obesity: an update. Curr Obes Rep 4:122–130. https://doi.org/10.1007/s13679-014-0129-4
doi: 10.1007/s13679-014-0129-4 pubmed: 25741455 pmcid: 4338356
McCarty MF (2000) The origins of western obesity: a role for animal protein? Med Hypotheses 54:488–494. https://doi.org/10.1054/mehy.1999.0882
doi: 10.1054/mehy.1999.0882 pubmed: 10783494
You W, Henneberg M (2016) Meat consumption providing a surplus energy in modern diet contributes to obesity prevalence: an ecological analysis. BMC Nutr 2:1–11. https://doi.org/10.1186/s40795-016-0063-9
doi: 10.1186/s40795-016-0063-9
Pedersen P, Milman N (2009) Genetic screening for HFE hemochromatosis in 6,020 Danish men: penetrance of C282Y, H63D, and S65C variants. Ann Hematol 88:775–784. https://doi.org/10.1007/s00277-008-0679-1
doi: 10.1007/s00277-008-0679-1 pubmed: 19159930
Whitfield JB, Cullen LM, Jazwinska EC et al (2000) Effects of HFE C282Y and H63D polymorphisms and polygenic background on iron stores in a large community sample of twins. Am J Hum Genet 66:1246–1258. https://doi.org/10.1086/302862
doi: 10.1086/302862 pubmed: 10739755 pmcid: 1288192
Bacon BR, Britton RS (2008) Clinical penetrance of hereditary hemochromatosis. N Engl J Med 25:183–190. https://doi.org/10.1056/nejme078215
doi: 10.1056/nejme078215
Iglesias Vázquez L, Arija V, Aranda N et al (2019) The effectiveness of different doses of iron supplementation and the prenatal determinants of maternal iron status in pregnant spanish women: ECLIPSES study. Nutrients 11:2418. https://doi.org/10.3390/nu11102418
doi: 10.3390/nu11102418 pmcid: 6835785
Fernandez-Cao JC, Arija V, Aranda N et al (2013) Heme iron intake and risk of new-onset diabetes in a Mediterranean population at high risk of cardiovascular disease: an observational cohort analysis. BMC Public Health 13:1042. https://doi.org/10.1186/1471-2458-13-1042
doi: 10.1186/1471-2458-13-1042 pubmed: 24188615 pmcid: 4228354
Hu PJ, Ley SH, Bhupathiraju SN et al (2017) Associations of dietary, lifestyle, and sociodemographic factors with iron status in Chinese adults: a cross-sectional study in the China Health and nutrition survey. Am J Clin Nutr 105:503–512. https://doi.org/10.3945/ajcn.116.136861
doi: 10.3945/ajcn.116.136861 pubmed: 28031193
Péneau S, Dauchet L, Vergnaud AC et al (2008) Relationship between iron status and dietary fruit and vegetables based on their vitamin C and fiber content. Am J Clin Nutr 87:1298–1305. https://doi.org/10.1093/ajcn/87.5.1298
doi: 10.1093/ajcn/87.5.1298 pubmed: 18469253
Harrison-Findik DD (2007) Role of alcohol in the regulation of iron metabolism. World J Gastroenterol 13:4925–4930. https://doi.org/10.3748/wjg.v13.i37.4925
doi: 10.3748/wjg.v13.i37.4925 pubmed: 17854133 pmcid: 4434614
Milman N, Kirchhoff M (1996) Relationship between serum ferritin, alcohol intake, and social status in 2235 Danish men and women. Ann Hematol 72:145–151. https://doi.org/10.1007/s002770050153
doi: 10.1007/s002770050153 pubmed: 8766257
White A, Nicolas G, Foster K (1993) Health Survey for England 1991. National Centre for Social Research, UK Data Archive. GB 1956 HSE
Whitfield JB, Zhu G, Heath AC et al (2001) Effects of alcohol consumption on indices of iron stores and of iron stores on alcohol intake markers. Alcohol Clin Exp Res 25:1037–1045. https://doi.org/10.1111/j.1530-0277.2001.tb02314.x
doi: 10.1111/j.1530-0277.2001.tb02314.x pubmed: 11505030
Mehta K, Farnaud S, Patel VB (2016) Molecular effects of alcohol on iron metabolism. In: Patel VB (ed) Molecular aspects of alcohol and nutrition: a the volume in the molecular nutrition series. Elsevier Inc., Amsterdam, pp 355–368
doi: 10.1016/B978-0-12-800773-0.00028-8
Ghio AJ, Hilborn ED, Stonehuerner JG et al (2008) Particulate matter in cigarette smoke alters iron homeostasis to produce a biological effect. Am J Respir Crit Care Med 178:1130–1138. https://doi.org/10.1164/rccm.200802-334OC
doi: 10.1164/rccm.200802-334OC pubmed: 18723436
Lee CH, Goag EK, Lee SH et al (2016) Association of serum ferritin levels with smoking and lung function in the Korean adult population: analysis of the fourth and fifth Korean National Health and Nutrition Examination Survey. Int J Chron Obs Pulmon Dis 11:3001–3006. https://doi.org/10.2147/COPD.S116982
doi: 10.2147/COPD.S116982
Zhang WZ, Butler JJ, Cloonan SM (2020) Smoking-induced iron dysregulation in the lung. Free Radic Biol Med 133:238–247. https://doi.org/10.1016/j.freeradbiomed.2018.07.024
doi: 10.1016/j.freeradbiomed.2018.07.024
Munasinghe LL, Ekwaru JP, Mastroeni MF et al (2019) The association of serum 25-hydroxyvitamin D concentrations with elevated serum ferritin levels in normal weight, overweight and obese Canadians. PLoS ONE 14:e0213260. https://doi.org/10.1371/journal.pone.0213260
doi: 10.1371/journal.pone.0213260 pubmed: 30845159 pmcid: 6405102
Broderstad A, Smith-Sivertsen T, Marie Dahl I et al (2006) Serum levels of iron in Sør-Varanger northern Norway—an iron mining municipality. Int J Circumpolar Health 65:432–442. https://doi.org/10.3402/ijch.v65i5.18131
doi: 10.3402/ijch.v65i5.18131 pubmed: 17319087
McClung JP, Martini S, Murphy NE et al (2013) Effects of a 7-day military training exercise on inflammatory biomarkers, serum hepcidin, and iron status. Nutr J 12:141. https://doi.org/10.1186/1475-2891-12-141
doi: 10.1186/1475-2891-12-141 pubmed: 24188143 pmcid: 3830559
Skarpańska-Stejnborn A, Basta P, Trzeciak J, Szcześniak-Pilaczyńska Ł (2015) Effect of intense physical exercise on hepcidin levels and selected parameters of iron metabolism in rowing athletes. Eur J Appl Physiol 115:345–351. https://doi.org/10.1007/s00421-014-3018-3
doi: 10.1007/s00421-014-3018-3 pubmed: 25311752

Auteurs

Lucía Iglesias-Vázquez (L)

Research group of Nutrition and Mental Health (NUTRISAM), Unit of Nutrition and Public Health, Faculty of Medicine and Health Sciences, Universitat Rovira i Virgili (URV), Tarragona, Spain.
Institut d'Investigació Sanitària Pere Virgili (IISPV), Reus, Spain.

Victoria Arija (V)

Research group of Nutrition and Mental Health (NUTRISAM), Unit of Nutrition and Public Health, Faculty of Medicine and Health Sciences, Universitat Rovira i Virgili (URV), Tarragona, Spain. victoria.arija@urv.cat.
Institut d'Investigació Sanitària Pere Virgili (IISPV), Reus, Spain. victoria.arija@urv.cat.
Institut d'investigació en Atenció Primària (IDIAP) Jordi Gol, Institut Català de la Salut (ICS), Barcelona, Spain. victoria.arija@urv.cat.

Núria Aranda (N)

Research group of Nutrition and Mental Health (NUTRISAM), Unit of Nutrition and Public Health, Faculty of Medicine and Health Sciences, Universitat Rovira i Virgili (URV), Tarragona, Spain.
Institut d'Investigació Sanitària Pere Virgili (IISPV), Reus, Spain.

Elom K Aglago (EK)

International Agency for Research on Cancer (IARC), Lyon, France.

Amanda J Cross (AJ)

Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.

Matthias B Schulze (MB)

Department of Molecular Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany.
Institute of Nutritional Science, University of Potsdam, Nuthetal, Germany.

Daniel Quintana Pacheco (D)

Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Tilman Kühn (T)

Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Elisabete Weiderpass (E)

International Agency for Research on Cancer (IARC), Lyon, France.

Rosario Tumino (R)

Cancer Registry and Histopathology Department, Provincial Health Authority (ASP 7) Ragusa, Ragusa, Italy.

Daniel Redondo-Sánchez (D)

Escuela Andaluza de Salud Pública (EASP), Granada, Spain.
Instituto de Investigación Biosanitaria ibs.GRANADA, Granada, Spain.
Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.

Maria Santucci de Magistris (MS)

Azienda Ospedialiera Universitaria (A.O.U.) Federico II, Naples, Italy.

Domenico Palli (D)

Cancer Risk Factors and Life-Style Epidemiology Unit Institute for Cancer Research, Prevention and Clinical Network (ISPRO), Villa delle Rose, Florence, Italy.

Eva Ardanaz (E)

Navarra Public Health Institute, Pamplona, Spain.
IdiSNA, Navarra Institute for Health Research, Pamplona, Spain.
CIBER Epidemiology and Public Health (CIBERESP), Madrid, Spain.

Nasser Laouali (N)

Paris-Saclay University, UVSQ, University Paris-Sud, Inserm, Gustave Roussy, "Exposome and Heredity" Team, CESP, 94805, Villejuif, France.

Emily Sonestedt (E)

Nutritional Epidemiology, Department of Clinical Sciences Malmö, Lund University, Malmö, Sweden.

Isabel Drake (I)

Nutritional Epidemiology, Department of Clinical Sciences Malmö, Lund University, Malmö, Sweden.

Lucía Rizzolo (L)

Unit of Nutrition and Cancer, Catalan Institute of Oncology - ICO, Nutrition and Cancer Group, Bellvitge Biomedical Research Institute -(IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.

Carmen Santiuste (C)

CIBER Epidemiology and Public Health (CIBERESP), Madrid, Spain.
Department of Epidemiology, Murcia Regional Health Council, IMIB-Arrixaca, Murcia, Spain.

Carlotta Sacerdote (C)

Unit of Cancer Epidemiology, Città Della Salute e Della Scienza University-Hospital, Via Santena 7, 10126, Turin, Italy.

Ramón Quirós (R)

EPIC Asturias, Public Health Directorate, Asturias, Spain.

Pilar Amiano (P)

CIBER Epidemiology and Public Health (CIBERESP), Madrid, Spain.
Public Health Division of Gipuzkoa, BioDonostia Research Institute, Donostia-San Sebastian, Spain.

Antonio Agudo (A)

Unit of Nutrition and Cancer, Catalan Institute of Oncology - ICO, Nutrition and Cancer Group, Bellvitge Biomedical Research Institute -(IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.

Paula Jakszyn (P)

Unit of Nutrition and Cancer, Catalan Institute of Oncology - ICO, Nutrition and Cancer Group, Bellvitge Biomedical Research Institute -(IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain. paujak@iconcologia.net.
Blanquerna School of Health Sciences, Ramon Llull University, Barcelona, Spain. paujak@iconcologia.net.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH